The study highlights the need for more research to focus on African demographics on the continent to personalise treatments ...

New data support tailoring regional nodal irradiation in patients treated with neoadjuvant chemotherapy on the basis of their ...

The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

ERC Advanced Grants worth a total of €721m were awarded to 281 researchers, with UCD's Prof Kylie Jarrett and Dr Barry Wardell among the winners.

Q4 2025 Earnings Call Transcript June 17, 2025 John Wiley & Sons, Inc. beats earnings expectations. Reported EPS is $1.37, ...

Oesophageal adenocarcinoma has an extremely poor prognosis, and improving outcomes via therapy remains particularly challenging in such a heterogeneous cancer. Another avenue for improving outcomes ...

The worse overall survival seen in transgender and gender-diverse patients may be due to treatment differences or non-breast cancer causes, researchers say.

Final analysis of KEYNOTE-A18 showed that pembrolizumab plus concurrent chemoradiation showed sustained PFS/OS benefits in ...

On Thursday, the U.S. House of Representatives advanced Republican budget legislation that would substantially increase the tax on Yale’s endowment investment income — which could limit students’ ...

Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.3 billion in its U.S.

Extended follow-up data from the CheckMate 274 trial have further solidified adjuvant nivolumab’s position as a standard of ...